GYNALGIN. 10 tablets

The composition of GYNALGIN:
Chlorquinaldol 0,10 g and Metronidazol 0,25 g. The combined action of these two components occurs with a very good effect in the treatment of inflammatory conditions in the vagina. Hlorkvinaldolat exhibits bactericidal effect on gram-negative and gram-positive bacteria, as well as antifungal, antiprotozoal and keratoplastichno action. Metronidazole exhibits strong antiprotozoal and antibacterial activity against anaerobic bacteria.
GYNALGIN recommended as a drug of choice in the treatment of inflammation of the vagina caused by bacteria, fungi, Escherichia coli, Staphylococcus albus coagulase-negative, Streptococcus beta, Dyphterion, Enterococcus, Enterobacter, Staphylococcus aureus, coagulase-positive and invasion of Trichomonas vaginalis. It is known that more than half of women suffer from any vaginal infections are largely caused by the above pathogens. Therefore GYNALGIN can be an effective tool in the practice of the family doctor.
 
Contraindications of GYNALGIN are:
hypersensitivity to the drug; to avoid application during pregnancy and lactation.
 
GYNALGIN well tolerated. Very rarely experience side effects such as itching of the vagina or vulva, which resolves spontaneously after treatment.
 
GYNALGIN dosed at 1 vaginal tablet daily vaginal, most preferably at night before sleeping, for 10 days. If necessary, the treatment is repeated. As is well known, if the invasion of Trichomonas vaginalis is present and the partner, it must be treated with the appropriate oral preparats form of release .